Mckesson Shows Improved Relative Strength; Still Shy Of Benchmark
The Relative Strength (RS) Rating for Mckesson headed into a higher percentile Thursday, as it got a lift from 69 to 72.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
History reveals that the top-performing stocks typically have an RS Rating of at least 80 as they begin their biggest runs. See if Mckesson can continue to show renewed price strength and hit that benchmark.
Mckesson is working on a flat base with a 210.10 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
Mckesson saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 18% to 101%. Revenue rose from 1% to 13%.
Mckesson earns the No. 1 rank among its peers in the Medical-Wholesale Drugs industry group.